Drug class

Angiotensin Converting Enzyme (ACE) Inhibitors

Angiotensin Converting Enzyme (ACE) Inhibitors are an established pharmacologic class of cardiovascular agents that lower blood pressure and reduce cardiac workload. Read more about Angiotensin Converting Enzyme (ACE) Inhibitors

191 drugs in this class 69 manufacturers

Advertisement

Drugs in Angiotensin Converting Enzyme (ACE) Inhibitors

Showing 172–180 of 191 drugs

ENALAPRIL MALEATE

ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS · HYPERTENSION ·+2
RISING PHARM

CAPTOPRIL

ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS · DIABETIC NEPHROPATHY ·+3
AVKARE

QUINAPRIL HCL

ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS · HYPERTENSION ·+1
GREENSTONE-MYLA

ENALAPRIL MALEATE

ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS · HYPERTENSION ·+2
TARO/SUN PHARMA

RAMIPRIL

ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS · HYPERTENSION ·+4
GSMS, INC.

ENALAPRIL MALEATE

ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS · HYPERTENSION ·+2
AMICI PHARMA, I
Filter & compare in the drug finder → Opens the drug finder with Angiotensin Converting Enzyme (ACE) Inhibitors preselected. Add indication or manufacturer filters there.

About Angiotensin Converting Enzyme (ACE) Inhibitors.

Angiotensin Converting Enzyme (ACE) Inhibitors are an established pharmacologic class of cardiovascular agents that lower blood pressure and reduce cardiac workload.

They function by competitively blocking the angiotensin-converting enzyme, which prevents the conversion of angiotensin I to the potent vasoconstrictor angiotensin II and decreases aldosterone secretion, thereby promoting systemic vasodilation and natriuresis.

Clinically, medications in this class are widely indicated for the management of essential hypertension, heart failure with reduced ejection fraction, and acute myocardial infarction.

They are also utilized to provide renal protection and slow the progression of chronic kidney disease, particularly diabetic nephropathy.